95 results
8-K
EX-99.1
ANIX
Anixa Biosciences Inc
7 Dec 23
Regulation FD Disclosure
6:01am
that:
The majority of patients developed ELISpot (T-cell) responses that met the rigorous protocol-specified definition of an immune response, with a measurable … found post-lactation in normal, aging tissues, but is present in the majority of triple-negative breast cancers. Activating the immune system against
8-K
EX-99.1
ANIX
Anixa Biosciences Inc
17 Apr 23
Anixa Biosciences and Cleveland Clinic Present Positive Data for Phase 1 Study of Breast Cancer Vaccine
1:45pm
-specific lactation protein, α-lactalbumin, which is no longer found post-lactation in normal, aging tissues, but is present in the majority of triple
S-8
8mot24q19d kb973ozo1
4 Jan 22
Registration of securities for employees
4:12pm
8-K
15pt tcgf5mv
27 May 21
Submission of Matters to a Vote of Security Holders
4:31pm
8-K
EX-4.1
2pe8y2aw7t7vwrc
24 Mar 21
Entry into a Material Definitive Agreement
4:28pm
8-K
EX-1.1
q9n02
24 Mar 21
Entry into a Material Definitive Agreement
4:28pm
424B5
he0hn
24 Mar 21
Prospectus supplement for primary offering
4:15pm
424B5
to2i0swa0f9irdym
22 Mar 21
Prospectus supplement for primary offering
5:16pm
S-8
6v8f jnhybmt07209x
7 Jan 21
Registration of securities for employees
4:18pm
8-K
EX-3.1
qug90hnx
17 Aug 20
Amendments to Articles of Incorporation or Bylaws
8:31am